These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3948920)

  • 1. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors.
    Köhler C; Hall H; Gawell L
    Eur J Pharmacol; 1986 Jan; 120(2):217-26. PubMed ID: 3948920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain.
    Hall H; Köhler C; Gawell L
    Eur J Pharmacol; 1985 May; 111(2):191-9. PubMed ID: 4018125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride.
    Köhler C; Karlsson-Boethius G
    J Neural Transm; 1989; 76(1):13-28. PubMed ID: 2523467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C; Hall H; Ogren SO; Gawell L
    Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502.
    Closse A; Camps M; Wanner A; Palacios JM
    Brain Res; 1988 Feb; 440(1):123-32. PubMed ID: 2965955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.
    Köhler C; Radesäter AC
    Neurosci Lett; 1986 May; 66(1):85-90. PubMed ID: 2940480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain.
    Köhler C; Radesäter AC; Karlsson-Boethius G; Bryske B; Widman M
    J Neural Transm Gen Sect; 1992; 87(1):49-62. PubMed ID: 1531593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
    Köhler C; Karlsson-Boethius G
    J Neural Transm; 1988; 73(2):87-100. PubMed ID: 2974879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.
    Köhler C; Fuxe K; Ross SB
    Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ; Marshall JF
    Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
    Dubois A; Savasta M; Curet O; Scatton B
    Neuroscience; 1986 Sep; 19(1):125-37. PubMed ID: 2946980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
    Hall H; Högberg T; Halldin C; Köhler C; Ström P; Ross SB; Larsson SA; Farde L
    Psychopharmacology (Berl); 1991; 103(1):6-18. PubMed ID: 1672460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.